Besterra (TSE:1433) Q1 FY2027 (3 months, Feb–Apr 2026): Revenue +29.3% to JPY 3.27bn, Operating Profit +164.1% to JPY 353M. Full-year FY2027 forecast: Revenue JPY 13.0bn (+16.7%), OP JPY 1.0bn (+34.9%).
CellSource (TSE:4880) Co., Ltd. FY2026 Analysis: Guidance Points to Strategic Investment Phase Ahead
Haba (TSE:6309) Industrial Co., Ltd. Q2 FY2026 Analysis: Strong Guidance Signals Resilience Amid Operational Headwinds
Hamayuu (TSE:7682) FY2026 Analysis: Guidance Points to Accelerating Growth Amid Operational Focus
i-Mobile (TSE:6535) Q3 FY2026 Analysis: Profit Dip Amidst Strategic Focus on Consumer Services
Kakiyasu (TSE:2294) Honten Co., Ltd. FY2026 Analysis: Guidance Points to Cautious Stability Amid Margin Pressure
Kumiai (TSE:4996) Chemical Industry Co., Ltd. Q2 FY2026 Analysis: Strong Ordinary Income Driven by Non-Operating Gains
Sakata Seed Corporation FY2026 Analysis: Strong Margins Drive Beat (TSE:1377).
Silver-Life (TSE:9262) Q3 FY2026 Analysis: Strong Operational Leverage Drives Profit Growth
THE WHY HOW DO COMPANY, Inc. FY2026 Analysis: Revenue Growth Masks Profitability Concerns (TSE:3823).